🇺🇸 FDA
Patent

US 6822071

Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease

expired A61KA61K2039/505A61K39/00

Quick answer

US patent 6822071 (Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease) held by The Regents of the University of California expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K39/00